azacitidine and Mesothelial Neoplasms

azacitidine has been researched along with Mesothelial Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amatori, S; Bagaloni, I; Catalano, A; Donati, B; Fanelli, M; Lazzarini, R; Papalini, F; Pelicci, PG; Procopio, A; Rippo, MR	1

Other Studies

1 other study(ies) available for azacitidine and Mesothelial Neoplasms

Article	Year
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells. Lung cancer (Amsterdam, Netherlands), 2009, Volume: 66, Issue:2 Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Cycle; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Silencing; Humans; Neoplasms, Mesothelial; Pleural Neoplasms; Up-Regulation	2009

Article

Year

Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in malignant pleural mesothelioma (MPM) cells.

Lung cancer (Amsterdam, Netherlands), 2009, Volume: 66, Issue:2

Topics: Antimetabolites, Antineoplastic; Azacitidine; Cell Cycle; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Gene Silencing; Humans; Neoplasms, Mesothelial; Pleural Neoplasms; Up-Regulation

2009